DIA is a global organization fostering collaboration among life sciences and healthcare professionals to accelerate pharmaceutical and healthcare product development. This fall, DIA is offering a number of virtual conferences and events to network, learn about tools and methodologies for product development and research, discuss challenges, and share perspectives across sectors. Check out these opportunities to network and bring back new knowledge to apply to the development of new contraceptive technologies and innovation.
Events include:
Biosimilars Conference (October 6-7), where manufacturers, regulators, payers, prescribers, and patients will convene to share perspectives on success and equilibrium and to envision the biosimilars landscape for the coming years
Master Protocol Workshop (October 8-9 with preconference short course on October 5), where industry, regulatory and government agency, and NGO representatives will come together to explore new and ongoing Master Protocol trials for design, implementation, and operational learnings that can be built upon to enhance collaboration and sharing in clinical research
Combinations Product Conference (October 15-16), where you can learn about combination products, their development challenges, and regulatory questions emerging alongside this scientific advancement
DIA/FDA Complex Generic Drug-Device Combination Products Conference (October 19-20), where you can discover common review issues and challenges in the development and management of complex generic drug-device combination products, and gain insight into the efforts and ongoing research of the FDA Office of Generic Drugs (OGD) around appropriate science-based methodologies and evidence for the development of said products
Details and registration information can be found by following each of the links… be sure to take advantage of special rates and discounts when registering for multiple conferences!